Name
BrainsWay
What We Do
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in the United States and Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
Website
Categories (10)
Brain: Assessment / Stimulation, FDA-Cleared Medical Devices
Address
1 Van de Graaff Drive
Suite 405
Burlington, MA 01803
United States
Suite 405
Burlington, MA 01803
United States
Facebook
https://www.facebook.com/BrainswayDeepTMS/
LinkedIn
https://www.instagram.com/brainsway/
Twitter (X)
https://x.com/brainsway
